Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Brit Regulatory News (SBO)

Share Price Information for Schroder Brit (SBO)

Share Price is delayed by 15 minutes
Get Live Data
70.50    0.00 (0.00%)
Bid:
69.00
Ask:
72.00
Spread: 3.00 (4.348%)
Market Cap: £52.10m
SBO Live PriceLast checked at - London Stock Exchange

Intraday Schroder Brit Share Chart

Statement re Quarterly NAV

30 Mar 2026 07:00

RNS Number : 5041Y
Schroder British Opportunities Tst.
30 March 2026
 

Schroder British Opportunities Trust plc

 

Net Asset Value as at 31 December 2025

Schroder British Opportunities Trust plc (the "Company") announces its unaudited net asset value ("NAV") as at 31 December 2025 was £82.3 million or 111.3p per share (30 September 2025: £81.2 million or 109.9p per share), following the quarterly valuation of the Company's unquoted holdings. This represents an increase of 1.40p per share (1.27%) compared with the NAV reported at the prior quarter end.

The Company's daily NAV calculation re-values the quoted company holdings on a daily basis, and the unquoted holdings quarterly post period end. This latest quarterly valuation of the unquoted holdings will be reflected in the daily unaudited NAV per share as of 27 March 2026, which will be published later today.

Portfolio

As at 31 December 2025, the Company had 19 portfolio company positions comprising 12 unquoted and 7 quoted companies.

Financial performance (unaudited)

Attribution analysis £m

 

Quoted

Unquoted

Money Market Funds

Cash and cash equivalents

Other

NAV

 

 

 

 

 

 

 

 

Value as at 30.09.2025

 

11.3

57.2

9.6

1.1

2.0

81.2

+ Investments

-

10.5

4.3

(14.8)

-

-

- Realisations at value

(5.9)

-

(5.5)

11.4

-

-

+/- Fair value gains/(losses)

0.4

0.9

0.1

-

1.4

+/- Costs and other movements

-

-

-

3.4

(3.7)

(0.3)

Value as at 31.12.2025

 

5.8

68.6

8.5

1.1

(1.7)

82.3

Source: JPM, as of March 2026.

The 1.4% increase in NAV, from £81.2 million at 30 September 2025 to £82.3 million at 31 December 2025, comprised:

- Unquoted holdings: 1.1%

- Quoted holdings: 0.5%

- Money market funds: 0.2%

- Cost and other movements: -0.4%

We have continued to see strong earnings growth momentum across the unquoted portfolio in aggregate, with underlying financial performance across holdings remaining robust. As a result, the Company's unquoted holdings saw an aggregate fair value increase of £0.9 million (1.1%) during the quarter ended 31 December 2025. This increase was driven primarily by continued operational progress across the portfolio, with strong contributions from CFC Underwriting, Acturis and Arrive, reflecting underlying earnings growth and, in the case of Acturis, multiple expansion.

The Company's quoted holdings increased in fair value by £0.4 million supporting an overall uplift in NAV. Performance was led primarily by Watches of Switzerland Group and SSP Group, reflecting continued earnings momentum and improving trading conditions, particularly in the US and travel‑related end markets. In contrast, Bytes Technology detracted over the quarter, as the share price weakened amid concerns around near‑term growth expectations and a moderation in UK corporate IT spending.

Investment activity

On the unquoted side, the Company completed two new investments, JMG, a UK-based insurance broker, and CSL, one of the UK's leading B2B providers of critical connectivity IoT solutions.

Public equities continued to be reduced in line with the Board approved transition to a wholly private equity investment strategy. Following the March 2025 announcement and subsequent circular, the Company is exiting quoted holdings as it moves towards full private equity deployment.

Unquoted holdings

As at 30 September 2025

As at 31 December 2025

Holding

Fair value (GBP '000) 

% of total investments

Fair value (GBP '000) 

% of total investments

Expana¹

9'511

12.2%

9'710

11.7%

Arrive²

7'671

9.8%

8'024

9.7%

Pirum Systems

7'581

9.7%

7'670

9.3%

CFC Underwriting

5'648

8.3%

6'421

7.8%

Cera Care

6'514

7.2%

6'195

7.5%

CSL

-

-

5'612

6.8%

Acturis

5'041

6.5%

5'444

6.6%

Culligan

5'238

6.7%

5'285

6.4%

JMG

-

-

4'726

5.7%

Rapyd

4'160

5.3%

4'164

5.0%

Headfirst

3'835

4.9%

3'495

4.2%

Learning Curve

2'009

2.6%

1'844

2.2%

 

[1] Expana, formerly known as Mintec, rebranded in June 2024.

[2] Arrive, formerly known as EasyPark, rebranded in June 2025.

Past performance is not a guide to future performance and may not be repeated. The value of investments and the income from them may go down as well as up and investors may not get back the amounts originally invested. None of the information in this report is to be considered a recommendation to buy or sell any securities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVKZGZFDNNGVZM
Date   Source Headline
16th Jan 202611:18 amRNSNet Asset Value(s)
15th Jan 20263:40 pmRNSDirector/PDMR Shareholding
15th Jan 202611:56 amRNSNet Asset Value(s)
14th Jan 202611:56 amRNSNet Asset Value(s)
13th Jan 202611:19 amRNSNet Asset Value(s)
12th Jan 202611:59 amRNSNet Asset Value(s)
9th Jan 202611:57 amRNSNet Asset Value(s)
8th Jan 202611:59 amRNSNet Asset Value(s)
7th Jan 202611:37 amRNSNet Asset Value(s)
6th Jan 202611:24 amRNSNet Asset Value(s)
5th Jan 202611:51 amRNSNet Asset Value(s)
2nd Jan 202612:02 pmRNSNet Asset Value(s)
31st Dec 202511:47 amRNSNet Asset Value(s)
30th Dec 202511:55 amRNSNet Asset Value(s)
29th Dec 202511:45 amRNSNet Asset Value(s)
24th Dec 202511:23 amRNSNet Asset Value(s)
23rd Dec 202511:45 amRNSNet Asset Value(s)
22nd Dec 202511:40 amRNSNet Asset Value(s)
19th Dec 202510:42 amRNSNet Asset Value(s)
18th Dec 202511:22 amRNSNet Asset Value(s)
17th Dec 202511:18 amRNSNet Asset Value(s)
16th Dec 202511:51 amRNSNet Asset Value(s)
15th Dec 202512:15 pmRNSNet Asset Value(s)
12th Dec 202511:58 amRNSNet Asset Value(s)
11th Dec 202511:54 amRNSNet Asset Value(s)
10th Dec 202511:51 amRNSNet Asset Value(s)
9th Dec 20253:30 pmRNS-RResults analysis from Kepler Trust Intelligence
9th Dec 202511:54 amRNSNet Asset Value(s)
8th Dec 202511:51 amRNSNet Asset Value(s)
5th Dec 202511:53 amRNSNet Asset Value(s)
4th Dec 202512:00 pmRNSNet Asset Value(s)
3rd Dec 202511:52 amRNSNet Asset Value(s)
2nd Dec 202512:13 pmRNSNet Asset Value(s)
2nd Dec 20257:00 amRNSHalf-year Financial Report
1st Dec 202512:03 pmRNSNet Asset Value(s)
28th Nov 202511:59 amRNSNet Asset Value(s)
27th Nov 202511:42 amRNSNet Asset Value(s)
26th Nov 202511:41 amRNSNet Asset Value(s)
25th Nov 20254:52 pmRNSBlock listing Interim Review
25th Nov 202511:50 amRNSNet Asset Value(s)
24th Nov 202511:48 amRNSNet Asset Value(s)
21st Nov 202511:51 amRNSNet Asset Value(s)
20th Nov 202511:42 amRNSNet Asset Value(s)
19th Nov 202511:41 amRNSNet Asset Value(s)
18th Nov 202511:33 amRNSNet Asset Value(s)
17th Nov 202511:50 amRNSNet Asset Value(s)
14th Nov 202511:23 amRNSNet Asset Value(s)
13th Nov 202511:43 amRNSNet Asset Value(s)
12th Nov 202511:29 amRNSNet Asset Value(s)
11th Nov 202511:51 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.